Galapagos | GLPG - Debt

Stock Price
29.30
Daily Change
0.24 0.83%
Monthly
4.94%
Yearly
31.51%
Q1 Forecast
27.75

Galapagos reported EUR10.86M in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
argenx SE USD 43.15M 4.1M Jun/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Biogen USD 6.29B 309.5M Sep/2025
Genmab DKK 148M 5M Jun/2025
Gilead Sciences USD 24.95B 6M Jun/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
GRIFOLS EUR 8.82B 1.23B Jun/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Incyte USD 42.41M 5.29M Jun/2025
Merck EUR 9.4B 704M Jun/2025
Neurocrine Biosciences USD 439.1M 8.4M Jun/2025
Novartis USD 32.64B 1.37B Jun/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
UCB EUR 3.03B 12M Dec/2024
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025